基于影像组学的模型对接受放化疗的下咽癌患者无进展生存期的预后价值
研究纳入113例接受放化疗的下咽癌患者,随机分为训练组(n=80)和验证组(n=33),利用CECT和NCCT图像提取影像组学特征构建模型,联合临床变量建立列线图预测进展风险;联合模型在训练组和验证组的C-index分别为0.804和0.756,高危组中位PFS显著短于低危组。
要点
- 影像组学模型由4个显著特征组成,可在训练组和验证组中区分进展高危与低危患者(log-rank检验P=0.00016和P=0.0063)。
- 联合影像组学-临床模型在训练组C-index为0.804(95%CI 0.688-0.920),验证组为0.756(95%CI 0.605-0.907)。
- 训练组高危与低危患者中位PFS分别为9.5个月和19.0个月(P<0.0001),验证组分别为11.3个月和22.5个月(P=0.0063)。
核心结论
- 基于影像组学的模型可预测接受放化疗的下咽癌患者的进展风险,联合临床变量的列线图可用于个体化风险预测。
研究设计与样本
- 回顾性研究,共113例接受放化疗的下咽癌患者,随机分为训练组(n=80)和验证组(n=33);使用CECT和NCCT图像提取影像组学特征,采用LASSO和AIC方法筛选特征并构建模型,以C-index评估预后性能。
诊断标准与关键数值
- 影像组学模型由4个显著特征组成,在训练组和验证组中均能分层进展高危与低危组(log-rank检验P=0.00016和P=0.0063);联合模型C-index训练组0.804(95%CI 0.688-0.920),验证组0.756(95%CI 0.605-0.907);训练组高危 vs 低危中位PFS为9.5个月 vs 19.0个月(P<0.0001),验证组为11.3个月 vs 22.5个月(P=0.0063)。
临床应用与阅片要点
- 影像组学特征来自CECT和NCCT图像,为PFS的独立预测因素;联合显著影像组学特征与临床变量(外周侵犯和转移)构建的列线图可用于预测个体进展风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop a radiomics-based model to stratify the risk of early progression (local/regional recurrence or metastasis) among patients with hypopharyngeal cancer undergoing chemoradiotherapy and modify their pretreatment plans.
MATERIALS AND METHODS: We randomly assigned 113 patients into two cohorts: training (n = 80) and validation (n = 33). The radiomic significant features were selected in the training cohort using least absolute shrinkage and selection operator and Akaike information criterion methods, and they were used to build the radiomic model. The concordance index (C-index) was applied to evaluate the model's prognostic performance. A Kaplan-Meier analysis and the log-rank test were used to assess risk stratification ability of models in predicting progression. A nomogram was plotted to predict individual risk of progression.
RESULTS: Composed of four significant features, the radiomic model showed good performance in stratifying patients into high- and low-risk groups of progression in both the training and validation cohorts (log-rank test, p = 0.00016, p = 0.0063, respectively). Peripheral invasion and metastasis were selected as significant clinical variables. The combined radiomic-clinical model showed good discriminative performance, with C-indices 0.804 (95% confidence interval (CI), 0.688-0.920) and 0.756 (95% CI, 0.605-0.907) in the training and validation cohorts, respectively. The median progression-free survival (PFS) in the high-risk group was significantly shorter than that in the low-risk group in the training (median PFS, 9.5 m and 19.0 m, respectively; p [log-rank] < 0.0001) and validation (median PFS, 11.3 m and 22.5 m, respectively; p [log-rank] = 0.0063) cohorts.
CONCLUSIONS: A radiomics-based model was established to predict the risk of progression in hypopharyngeal cancer with chemoradiotherapy.
KEY POINTS: • Clinical information showed limited performance in stratifying the risk of progression among patients with hypopharyngeal cancer. • Imaging features extracted from CECT and NCCT images were independent predictors of PFS. • We combined significant features and valuable clinical variables to establish a nomogram to predict individual risk of progression.
引用
- Mo X, Wu X, Dong D, et al. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation. Eur Radiol. 2019. PMID: 31673835. doi:10.1007/s00330-019-06452-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。